Skip to Main Content

WASHINGTON — PhRMA has already spent $21 million on lobbying this year — a sum that puts it on course to smash its previous annual lobbying records.

The group, which represents dozens of major drug makers, spent nearly $6 million on advocacy in the third quarter of this year, according to lobbying disclosures released Monday, about $400,000 more than it spent in the same period last year. After an unprecedented first half of 2018, that total puts it just $4 million shy of a new record annual spend —and it hasn’t spent less than $4 million in a quarter since 2015.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.